Found: 7
Select item for more details and to access through your institution.
Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR-mediated activation of adipose tissue macrophages promotes obesity and insulin resistance.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32348-3
- By:
- Publication type:
- Article
Epidermal growth factor receptor activation is essential for kidney fibrosis development.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43226-x
- By:
- Publication type:
- Article
Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis.
- Published in:
- FASEB Journal, 2017, v. 31, n. 10, p. 4407, doi. 10.1096/fj.201601359RR
- By:
- Publication type:
- Article
Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
- Published in:
- 2021
- By:
- Publication type:
- journal article